Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54,790,889
-
Number of holders
-
174
-
Total 13F shares, excl. options
-
31,680,438
-
Shares change
-
+1,426,153
-
Total reported value, excl. options
-
$384,920,868
-
Value change
-
+$17,314,514
-
Put/Call ratio
-
35.75%
-
Number of buys
-
70
-
Number of sells
-
-89
-
Price
-
$12.15
Significant Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q1 2022
206 filings reported holding CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2022.
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 174 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31,680,438 shares
of 54,790,889 outstanding shares and own 57.82% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7,187,124 shares), VANGUARD GROUP INC (3,244,377 shares), FARALLON CAPITAL MANAGEMENT LLC (2,500,000 shares), DISCIPLINED GROWTH INVESTORS INC /MN (1,694,350 shares), STATE STREET CORP (1,680,599 shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (1,183,000 shares), Chescapmanager LLC (1,175,392 shares), JACOBS LEVY EQUITY MANAGEMENT, INC (918,256 shares), GEODE CAPITAL MANAGEMENT, LLC (804,625 shares), and DIMENSIONAL FUND ADVISORS LP (792,191 shares).
This table shows the top 174 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.